CAPLIPOINT Share Price Target 2030

CAGR-based price projection for Caplin Point Laboratories Limited (CAPLIPOINT) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (21.6% CAGR)
Rs 5,759
2030 Target
Base Case (54.1% CAGR)
Rs 14,825
2030 Target
Bull Case (178.5% CAGR)
Rs 158,410
2030 Target

Current Market Snapshot

CMP: Rs 2,631.90
52W High: Rs 2,867.40
52W Low: Rs 1,687.10
1Y CAGR: 137.3%
3Y CAGR: 54.1%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 3,201 Rs 4,055 Rs 7,331
2028 Rs 3,893 Rs 6,246 Rs 20,419
2029 Rs 4,735 Rs 9,623 Rs 56,873
2030 Rs 5,759 Rs 14,825 Rs 158,410

Other CAPLIPOINT Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the CAPLIPOINT share price target for 2030?

Based on historical growth analysis, the CAPLIPOINT share price target for 2030 ranges from Rs 5,759 (conservative) to Rs 14,825 (base case) to Rs 158,410 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of CAPLIPOINT?

The current market price of CAPLIPOINT (Caplin Point Laboratories Limited) is Rs 2,631.90. The 52-week high is Rs 2,867.40 and 52-week low is Rs 1,687.10.

Is CAPLIPOINT a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for CAPLIPOINT price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 21.6% CAGR), Base (54.1% CAGR), and Bull (optimistic at 178.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.